• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Infect Dis J . Changing Characteristics of Children With COVID-19 in Colorado Admitted During Different Variant Periods

tetano

Editor, Senior Moderator
Pediatr Infect Dis J


. 2023 Apr 20.
doi: 10.1097/INF.0000000000003944. Online ahead of print.
Changing Characteristics of Children With COVID-19 in Colorado Admitted During Different Variant Periods


Monika Jelic[SUP] 1 [/SUP], Lori Silveira[SUP] 1 [/SUP], Sean Lang[SUP] 1 [/SUP], Shane Curran-Hays[SUP] 1 [/SUP], Shea Boyer[SUP] 1 [/SUP], Brian Carter[SUP] 2 [/SUP], Ye Ji Choi[SUP] 3 [/SUP], Joellen Fresia[SUP] 2 [/SUP], Lilia C Maeda[SUP] 2 [/SUP], David Nerguizian[SUP] 2 [/SUP], Kelly Graff[SUP] 4 [/SUP], Lisa Abuogi[SUP] 1 [/SUP], Christiana Smith[SUP] 1 [/SUP]; Children and COVID-19 in Colorado study



Affiliations

Abstract

Background: Data are lacking on the impact of different severe acute respiratory syndrome coronavirus 2 variants in children and on pediatric vaccine effectiveness. We examined differences among children requiring hospital admission associated with coronavirus disease 2019 (COVID-19) during wild type, Delta and Omicron variant periods and calculated vaccine effectiveness at preventing symptomatic hospitalization during the Delta and Omicron variant periods.
Methods: We conducted a retrospective review of children younger than 21 years of age hospitalized with symptomatic COVID-19. Characteristics were compared between variant periods using Kruskal-Wallis or generalized Fisher exact tests. We estimated vaccine effectiveness in preventing symptomatic hospitalization.
Results: We included 115 children admitted during the wild type period, 194 during Delta and 226 during the Omicron periods. Median age (years) decreased (12.2 wild type, 5.9 Delta, 1.3 Omicron periods, P < 0.0001) over time. Children were less likely to have a comorbid condition, including diabetes or obesity, and had shorter admissions during Omicron compared with the wild type and Delta periods. Intensive care unit admissions and respiratory support requirements were highest during the Delta period (P = 0.05). Among children ≥12 years, adjusted vaccine effectiveness at preventing symptomatic hospitalization was 86% during Delta and 45% during Omicron periods.
Conclusions: Children hospitalized with COVID-19 during later variant periods were younger and less likely to have comorbidities. Children admitted during the Delta variant period required more intensive care and respiratory support compared to other variant periods. Vaccination was less effective at preventing symptomatic hospital admission during the Omicron period compared to the Delta period.
 
Back
Top Bottom